How to Give Steroids for Oral Ulcers
Start with topical high-potency corticosteroids as first-line therapy: use dexamethasone mouth rinse (0.1 mg/ml) for multiple or hard-to-reach ulcers, or clobetasol gel/ointment (0.05%) for limited, accessible ulcers 1.
Stepwise Treatment Algorithm
Step 1: Topical Corticosteroids (First-Line)
For multiple or difficult-to-reach ulcers:
- Dexamethasone mouth rinse 0.1 mg/ml
- Apply 3 times daily after meals for 5 days 2
- This achieves 83% healing rate with significant pain reduction (median pain score drops from 5 to 1) 2
- No systemic absorption detected on serum testing, confirming safety 2
For limited, easily accessible ulcers:
- Clobetasol gel or ointment 0.05%
- Apply directly to ulcer sites
- More concentrated delivery for localized lesions 1
Step 2: Intralesional Steroids (If No Resolution)
When topical therapy fails:
- Triamcinolone acetonide intralesional injection
- Dose: 12 mg per injection (median dose, range 2-36 mg) 3
- Frequency: Weekly injections, total dose up to 28 mg 1
- Continue concurrent topical clobetasol 0.05% 1
- Expect median 2 injections (range 1-5) for complete resolution 3
- 81.7% complete resolution achieved in median 96 days 3
- After first injection: ulcer size reduces from median 1 cm to 0.3 cm 3
Step 3: Systemic Corticosteroids (For Severe/Recurrent Cases)
Reserved for highly symptomatic, recurrent, or esophageal ulcers:
- High-dose pulse: 30-60 mg (or 1 mg/kg) oral prednisone/prednisolone
- Duration: 1 week at full dose
- Taper over second week 1
- Brings symptoms under rapid control 1, 4
Key Clinical Considerations
Pain management integration:
- Use topical anesthetics (viscous lidocaine 2%) before applying steroids if painful 1
- Consider coating agents to improve tolerability
- Nearly half of patients benefit from concomitant topical steroid + anesthetic therapy 3
Common pitfalls to avoid:
- Don't jump to systemic steroids without trying topical therapy first—topical dexamethasone shows no systemic absorption and excellent efficacy 2
- Don't use inadequate dosing frequency—3 times daily application is critical for efficacy 2
- Don't continue ineffective topical therapy beyond reasonable trial—escalate to intralesional if no improvement 1
Specific indications by ulcer type: The intralesional approach is particularly effective for traumatic ulcers (40.8% of cases), chronic graft-versus-host disease ulcers (24.7%), and oral lichen planus (20.4%) 3. These inflammatory and immune-mediated ulcers respond well to the concentrated steroid delivery.
Safety profile: The evidence strongly supports safety across all routes. Topical dexamethasone shows undetectable serum levels (<0.502 ng/mL) even with regular use 2, and no severe adverse reactions or oral candidiasis were reported in the reviewed studies 5.